Avecho Biotechnology Limited (FRA:OEZ)

Market Cap	20.94M +268.5%
Revenue (ttm)	770.70K +306.9%
Net Income	-2.02M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	125
Open	0.0050
Previous Close	0.0050
Day's Range	0.0050 - 0.0050
52-Week Range	0.0005 - 0.0065
Beta	n/a
RSI	46.93
Earnings Date	Feb 26, 2026

About Avecho Biotechnology

Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, the Americas, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery. Its human health portfolio covers delivery of pharmaceutical products for pain and dermatology applications through gels, injectables, and patches. In additio...

• Industry: Pharmaceutical Preparations
• Founded: 1992
• Employees: 15
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OEZ

Financial Performance

In 2024, Avecho Biotechnology's revenue was 1.13 million, an increase of 139.19% compared to the previous year's 473,551. Losses were -3.12 million, -9.15% less than in 2023.

Financial numbers in AUD